[1]
Purbonegoro, T. et al. 2024. BROLUCIZUMAB FOR WET-AGED RELATED MACULAR DEGENERATION PATIENTS : TOO GOOD TO BE TRUE . Ophthalmologica Indonesiana. 49, S1 (Feb. 2024), 98–102. DOI:https://doi.org/10.35749/99z4g547.